Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate.
D000328:Adult; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D002792:Cholestyramine Resin / Q000627:therapeutic use*; D004586:Electrophoresis; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy* / Q000235:genetics*; D008074:Lipoproteins / Q000097:blood; D008286:Malabsorption Syndromes / Q000150:complications; D008297:Male; D014280:Triglycerides / Q000097:blood; D014973:Xanthomatosis / Q000150:complications / Q000188:drug therapy*
D000924:Anticholesteremic Agents; D008074:Lipoproteins; D014280:Triglycerides; D002792:Cholestyramine Resin; D002784:Cholesterol